Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles

  • Small organizations can employ occ-health practices effectively

    Even though many small employers dont think they can afford to spend money on a workplace health and safety program based on OSHA mandates, very few can afford not to put at least some measures in from the beginning.
  • OSHA makes respirator fit-testing more difficult

    Recent changes to OSHA requirements related to tuberculosis and respirator fit testing have prompted concern from many health care professionals who are responsible for the health and safety, including fit testing, of health care facility employees, a recent survey of occupational health nurses reveals.
  • Call center rings up WC savings

    You cant manage workers compensation costs if you cant track those costs. That basic truth led OSF Saint Francis Medical Center in Peoria to rethink its system, beginning with the first report of a work-related injury.
  • More women are looking at intrauterine devices

    Are more women at your family planning facility requesting information on intrauterine contraception? Chances are you are seeing an increase in interest: Almost 30% of respondents to the 2004 Contraceptive Technology Update Contraception Survey say they have performed six to 25 intrauterine device (IUD) insertions in the last year, up slightly from 2003s figures.
  • New study eyes link to DMPA use, STD risk

    Findings from a just-published study indicate that women who use the contraceptive injection depot medroxyprogesterone acetate (DMPA, marketed as Depo-Provera, Pfizer, New York City) appear to have a threefold increased risk of acquiring chlamydia and gonorrhea when compared to women not using a hormonal contraceptive.
  • DMPA: Check snapshot of current clinical use

    The next patient in your exam room is a 16-year-old young woman who says she needs effective contraception. She has tried oral contraceptives (OCs), but she says she has trouble remembering to take a daily pill. What options can you offer her?
  • Full November 2004 issue in PDF

  • New contraceptives widen choices, but the Pill still is a top selection

    While the contraceptive transdermal patch (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) and the contraceptive vaginal ring (NuvaRing, Organon, West Orange, NJ) are gaining increased use among women, many providers report that oral contraceptives (OCs) remain a popular form of birth control.
  • Survey Profile

  • Pill remains powerful force in contraception

    Take a look at the last 10 patient charts in your outbox. If oral contraceptives (OCs) were prescribed, which ones were selected? When it comes to prescriptions for younger women, about 24% of respondents to the 2004 Contraceptive Technology Update Contraception Survey say their No. 1 pill of choice is Ortho Tri-Cyclen Lo (Ortho-McNeil Pharmaceutical, Raritan, NJ).